Investigation of the molecular mechanism responsible for colitis improvement revealed that aloperine treatment in Jurkat cells attenuated the levels of p-PI3K p85, p-Akt, and p-mTOR (major molecules of PI3K/Akt/mTOR pathway). The gene discussed is AKT1; the disease is colitis.